Document:

AMENDMENT NO. 1 TO LICENSE AGREEMENT, JUNE 19, 2000

 Exhibit 10.7 
  
 CONFIDENTIAL TREATMENT 
  
 AMENDMENT NO. 1 TO LICENSE AGREEMENT 
 BETWEEN
THE UNIVERSITY OF SOUTHERN CALIFORNIA 
 AND MARET CORPORATION 
  
 This Amendment No. 1 to License Agreement (the “Amendment”) is entered into this 19th day of June, 2000.

  
 RECITALS 
  
 A. The University of Southern California (“USC”) and Maret
Corporation (“Licensee”) are parties to that certain License Agreement, USC FILE 2146B, USC FILE 2429, AND USC FILE 2430 (the “License Agreement”) relating to specifically identified patents. 
  
 B. USC and Licensee are parties to certain Research Agreements, effective
August 31, 1994 and dated, July 18, 1997, as amended (the “Prior Research Agreements”). Under the terms of the Prior Research Agreements, Licensee is granted the option to license “University Intellectual Property” (as that term
is defined in the Prior Research Agreements). Licensee has exercised that option and it is the intent of the parties that Licensee is granted a license for all University Intellectual Property in accordance with the terms of the License Agreement.

  
 C. A new Research Agreement (the “New Research
Agreement”) is being executed contemporaneously by the parties that provides for the option to license University Intellectual Property (as that term is defined in the New Research Agreement). 
  
 D. In addition to the patents that are currently the subject of the License
Agreement, the parties desire to amend the License Agreement to provide for the license of University Intellectual Property under the Prior Research Agreements or arising from the research activity funded by the Licensee between January 1, 2000
through the date of New Research Agreement (the “Interim Period”). 
  
 E. The parties also desire to amend the License Agreement to conform the definition of “Field of Use” to the research previously conducted under the Prior Research Agreements and in the Interim Period.

  
 AGREEMENT 
  
 NOW, THEREFORE, the parties agree as follows: 
  

	 	1.	Section 2. DEFINITIONS is amended as follows: 

  

	 	1.1	Section 2a is deleted and amended to read as follows: 

 2a. The term “PATENT” or “PATENTS” shall mean any and all patent applications listed
in Appendix A and any and all patent applications relating to inventions arising from research conducted under Prior Research Agreements or research funded by Licensee during the Interim Period, and any and all patents issued with respect to any of
such patent applications or any continuation, division, extension or reissue thereof, and any and all foreign patents issuing from any patent filed which corresponds to claims contained in any of the foregoing patents or applications. 
  

	 	1.2	Section 2c is deleted and amended to read as follows: 

  
 2c. “FIELD OF USE” shall mean (i) repair or remodeling of tissue or blood vessels, and (ii) other areas claimed in PATENTS. 
  
 2h. “TECHNOLOGY” shall mean any know-how, trade secrets,
biological materials, copyrightable works, copyrights, formulas, processes, techniques, developments, and advances or other information or materials or any technology either arising out of, conceived, developed or reduced to practice under the
RESEARCH AGREEMENT in the FIELD OF USE. 
  

	 	1.4	Section 2j is deleted and amended to read as follows: 

  
 2j. “RESEARCH AGREEMENT” shall mean the Research Agreements, effective August 31, 1994 and dated, July 18, 1997, as amended, the research
funded by Licensee during the Interim Period, the Research Agreement between USC and Licensee executed contemporaneously, and any and all future Research Agreements between USC and Licensee. 
  

	 	2.	Section 3. LICENSE is amended as follows: 

  

	 	2.1	Section 3ai is deleted and amended to read; 

  
 3ai. the exclusive worldwide license to use the PATENT(S) and TECHNOLOGY to manufacture and sell the PRODUCT(S); and 
  

	 	2.2	Section 3aii is deleted and amended to read: 

  
 3aii. the right to grant sublicenses to any PATENT or TECHNOLOGY licensed exclusively hereunder provided that any SUBLICENSEE agrees to be bound by the
terms and conditions of this Agreement applicable to SUBLICENSEES. 
  

	 	3.	Section 4. ROYALTY shall be amended as follows: 

  

	 	3.1	Section 4i shall be deleted and amended as follows: 

 4i. The obligation to pay a royalty under this Agreement on the NET SALES OF A PRODUCT shall be imposed
only once with respect to the same unit of the PRODUCT regardless of the number of valid issued or, assuming they were to issue, pending claims included within the PATENTS. Further, only one royalty shall be due on any single unit of a PRODUCT
whether such PRODUCT is a PATENT PRODUCT, a TECHNOLOGY PRODUCT or a combination of the two. If the PRODUCT may be both a PATENT PRODUCT and a TECHNOLOGY PRODUCT, then for the purposes of the payment of royalties under this Agreement, the PRODUCT
shall be deemed a PATENT PRODUCT. 
  

	 	4.	Section 11. SUBLICENSE PERMISSION is deleted and amended to read as follows: 

  

11. SUBLICENSE PERMISSION. Licensee may sublicense the PATENTS and TECHNOLOGY only with prior written permission from USC, which permission will not be
unreasonably withheld, if there is compliance of the Sublicensee with the specified terms in this Agreement. 
  

	 	5.	Section 14. PUBLICITY is deleted in its entirely and amended as follows: 

  
 14. PUBLICITY. Licensee may cite that it has a license and funding agreement with USC regarding technology from the USC School of Medicine. Any other use
of the name of USC for products, promotion or marketing-related purposes requires prior written USC approval. USC acknowledges that communications with prospective investors, lenders and other business affiliates as well as the SEC and other
regulatory agencies will require disclosure of the Licensee and USC relationship. USC retains the right to prior review of any disclosure of the relationship with Licensee. 
  

	 	6.	Section 17 NOTICES, REPORTS AND PAYMENTS is amended to read: 

  
 Notice shall be sent to the Licensee at the following address: 
  

Maret Corporation 
 Dr. Terence E. Winters, Chief Executive Officer 
 4041 McArthur Blvd., Suite 375 
 Newport Beach, California 92660 
  
 USC and Licensee hereby acknowledge that all parties have complied with all terms and provisions of the License Agreement and the Research Agreements to
be performed prior to the date of this Amendment. In all other respects, the License Agreement is hereby ratified and confirmed. In the case of direct conflict or conflict by reason of interpretation between any provision of this Amendment and the
License Agreement, the Amendment shall control and supercede the terms of the License Agreement. 

  

	 UNIVERSITY OF SOUTHERN CALIFORNIA
	  	 MARET CORPORATION

		
	 /s/ Dennis F. Dougherty

	  	 /s/ T. E. Winters

	 (Signature)
	  	 (Signature)

		
	 Dennis F. Dougherty

	  	 T. E. Winters

	 (Print or Type Name)
	  	 (Print of Type Name)

		
	 Senior Vice President of Administration

	  	 CEO

	 (Official Title)
	  	 (Official Title)

		
	 6/13/2000

	  	 6/19/2000

	 (Date)
	  	 (Date)

	[*]

  
 *Confidential Treatment Required.
Omitted portions filed with the Commission.1st Amendment to the Revolving Credit and Term Loan Agreement

 Exhibit 10.1 
  
 Execution Copy 
  
 AMENDMENT NO. 1 
  
 to that certain 
  
 REVOLVING CREDIT AND TERM LOAN AGREEMENT 
 dated as of September 30, 2002

  
 AMENDMENT NO. 1 (this “Amendment”),
dated as of November 4, 2003, to the Revolving Credit and Term Loan Agreement, dated as of September 30, 2002 (as amended and in effect from time to time, the “Credit Agreement”), is by and among (a) BUCA, INC. (the
“Borrower”), a Minnesota corporation, (b) BUCA RESTAURANTS, INC., a Minnesota corporation, BUCA RESTAURANTS 2, INC., a Minnesota corporation (as an original party and as successor by merger to BUCA (Nevada), Inc.),
BUCA RESTAURANTS 3, INC., a Minnesota corporation, BUCA INVESTMENTS, INC., a Minnesota corporation, BUCA (KANSAS), INC., a Kansas corporation, BUCA TEXAS RESTAURANTS, L.P., a Texas limited partnership, and BUCA TEXAS
BEVERAGE, INC., a Texas corporation (collectively, the “Guarantors”), (c) FLEET NATIONAL BANK and the other lending institutions listed on Schedule 1 attached thereto (the “Lenders”), (d)
FLEET NATIONAL BANK, as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders, and (e) SUNTRUST BANK, as syndication agent. 
  
 WHEREAS, the Borrower, the Required Lenders and the Administrative
Agent have agreed, on the terms and conditions set forth herein, to amend certain provisions of the Credit Agreement; 
  
 NOW THEREFORE, the parties hereto hereby agree as follows: 
  

§1. Defined Terms. Capitalized terms which are used herein without definition and which are defined in the Credit Agreement shall
have the same meanings herein as in the Credit Agreement. 

 §2. Amendments to the Credit Agreement. 
  
 (a) Applicable Margin. Section 1.1 of the Credit Agreement is hereby
amended by deleting the table in the definition of “Applicable Margin” and substituting the following table in lieu thereof: 
  

	Level

	  	 Leverage
 Ratio

	  	Base Rate
Loans

	 	 	Eurodollar
Rate Loans

	 
	 I
	  	Greater than or equal to 1.75:1.00	  	2.25	%	 	3.75	%
	 II
	  	Less than 1.75:1.00 but greater than or equal to 1.25:1.00	  	2.00	%	 	3.50	%
	 III
	  	Less than 1.25:1.00 but greater than or equal to 1.00:1.00	  	1.25	%	 	2.75	%
	 IV
	  	Less than 1.00:1.00 but greater than or equal to 0.75:1.00	  	1.00	%	 	2.50	%
	 V
	  	Less than 0.75:1.00	  	0.75	%	 	2.25	%

  
 (b) Sale/Leaseback
Transactions. Section 10.5.2.1(c) is hereby deleted in its entirety and Section 10.5.2.1(d) shall become Section 10.5.2.1(c). 
  
 (c) Leverage Ratio. Section 11.1 of the Credit Agreement is hereby amended by deleting the table in Section 11.1 and inserting the following table
in lieu thereof: 
  

	 Period

	  	Ratio

	 FQ3 2003 through FQ3 2004
	  	2.50:1.00
	 Thereafter
	  	1.75:1.00

  
 (d) Interest
Coverage Ratio. Section 11.2 of the Credit Agreement is hereby amended by deleting Section 11.2 in its entirety and inserting the following in lieu thereof: 
  

“11.2 Interest Coverage Ratio. The Borrower will not permit the Interest Coverage Ratio as at the end of any fiscal quarter of the Borrower
ending during any period described in the table set forth below to be less than any ratio set forth opposite such period in such table; provided that with respect to (i) FQ4 2003, the ratio shall be determined for that fiscal quarter, (ii)
FQ1 2004, the ratio shall be determined for the period of two consecutive fiscal quarters ended on the last day of that fiscal quarter, and (iii) FQ2 2004, the ratio shall be determined for the period of three consecutive fiscal quarters ended on
the last day of that fiscal quarter and (iv) each fiscal quarter thereafter, the ratio shall be determined for the Reference Period ended on the last day of that fiscal quarter: 
  

	 Period

	  	Ratio

	 FQ4 2003 through FQ3 2004
	  	1.40:1.00
	 FQ4 2004
	  	1.75:1.00
	 Thereafter
	  	5.00:1.00

  

 -2- 

 (e) Fixed Charge Coverage Ratio. Section 11.3 of the Credit Agreement is hereby amended by
deleting the table in Section 11.3 and inserting the following table in lieu thereof: 
  

	 Period

	  	Ratio

	 FQ3 2003 through FQ4 2004
	  	1.25:1.00
	 Thereafter
	  	1.55:1.00

  
 (f) Capital
Expenditures. Section 11.5.1 of the Credit Agreement is hereby amended by deleting Section 11.5.1 in its entirety and substituting the following in lieu thereof: 
  
 “11.5.1. Capital Expenditures. The Borrower will not make, or permit any Subsidiary of the
Borrower to make, aggregate Capital Expenditures for the Borrower and its Subsidiaries (a) in fiscal year 2003, in excess of $27,500,000, (b) in fiscal year 2004, in excess of $13,000,000 and (c) in each fiscal year thereafter, in excess of an
amount equal to the sum of (i) $30,000,000 plus (ii) thirty percent (30%) of Consolidated EBITDA for the prior fiscal year, provided, that if, during any fiscal year, the amount of Capital Expenditures permitted for such fiscal year is
not so utilized, the unused amount not in excess of $10,000,000 may be used in the next succeeding fiscal year but not in any subsequent fiscal year, such carried over amounts to be deemed used last.” 
  
 (g) Growth Capital Expenditures. Section 11.5.2 of the Credit
Agreement is hereby amended by deleting Section 11.5.2 in its entirety and substituting the following in lieu thereof: 
  
 “11.5.2. Growth Capital Expenditures. The Borrower will not make, or permit any Subsidiary of the Borrower to make, Growth
Capital Expenditures (including the signing of new leases) if the Pro Forma Leverage Ratio as of the time the Borrower or any Subsidiary of the Borrower commits to incur such Growth Capital Expenditures is greater than 1.75:1.00, provided,
that such Pro Forma Leverage Ratio restriction shall not prohibit the Borrower from making Growth Capital Expenditures otherwise permitted under §11.5.1 with respect to those Stores listed on Schedule 11.5.2.” 
  
 (h) Minimum Consolidated EBITDA. The following new Section 11.6 of the
Credit Agreement is hereby inserted following Section 11.5 of the Credit Agreement: 
  
 “11.6. Consolidated EBITDA. The Borrower will not permit Consolidated EBITDA to be less than (a) $5,500,000 for FQ4 2003 and
(b) $4,750,000 for FQ1 2004.” 
  

 -3- 

 §3. Waiver. The Required Lenders and the Administrative Agent hereby waive the
requirement that the Borrower comply with the provisions of §11.2 of the Credit Agreement for FQ3 2003. Additionally, the Required Lenders and the Administrative Agent hereby waive the requirement that the Borrower comply with the provisions of
§§11.1 and 11.3 of the Credit Agreement (prior to giving effect to this Amendment) for FQ3 2003, so long as the Borrower complies with §§11.1 and 11.3 of the Credit Agreement, after giving effect to this Amendment, for FQ3 2003.
Nothing contained in this Amendment shall be construed to imply a willingness on the part of the Lenders and the Administrative Agent to grant any similar or other future waivers of any of the terms and conditions of the Credit Agreement.

  
 §4. Conditions to Effectiveness. This
Amendment shall become effective upon the satisfaction of the following conditions precedent, all of the following to be in form and substance satisfactory to the Administrative Agent: 
  
 (a) Delivery of Amendment. The Administrative Agent shall have received a counterpart signature page to this
Amendment duly executed and delivered by the Borrower, each of the Guarantors and the Required Lenders. 
  
 (b) Fees. The Administrative Agent shall have received payment, for the pro rata account of each Lender which returns an executed counterpart
signature page to this Amendment to the Administrative Agent on or prior to 3:00pm (Boston time) on November 4, 2003, an amendment fee equal to 0.25% of the sum of such Lender’s Commitment and the outstanding principal amount of such
Lender’s Term Loan. 
  
 §5. Affirmation and
Acknowledgment of the Borrower and the Guarantors. 
  
 (a) The Borrower. The Borrower hereby ratifies and confirms all of its Obligations to the Lenders and the Administrative Agent and the Borrower hereby affirms its absolute and unconditional promise to pay to the Lenders and the
Administrative Agent the Loans and all other Obligations under the Credit Agreement, as amended hereby. 
  
 (b) The Guarantors. Each of the Guarantors hereby ratifies and confirms all of its Obligations to the Lenders and the Administrative Agent and each
of the Guarantors hereby affirms its unconditional and irrevocable guaranty of the Obligations under the Credit Agreement, as amended hereby. 
  

 -4- 

 §6. Representations and Warranties. Each of the Guarantors and the Borrower hereby
represents and warrants to the Administrative Agent and the Lenders as follows: 
  
 (a) Representation and Warranties. The representations and warranties of each of the Guarantors and the Borrower contained in the Credit Agreement and the other Loan Documents were true and correct in all
material respects as of the date when made and continue to be true and correct in all material respects on the date hereof, except to the extent of changes resulting from transactions contemplated or permitted by the Credit Agreement and the other
Loan Documents and changes occurring in the ordinary course of business that singly or in the aggregate are not materially adverse to the Guarantors and the Borrower, taken as a whole, or to the extent that such representations and warranties relate
expressly to an earlier date. 
  
 (b) Ratification,
Etc. Except as expressly amended or waived hereby, the Credit Agreement, and all documents, instruments and agreements related thereto, are hereby ratified and confirmed in all respects and shall continue in full force and effect. The Credit
Agreement shall, together with this Amendment, be read and construed as a single agreement. All references to the Credit Agreement in the Credit Agreement or any related agreement or instrument shall hereafter refer to the Credit Agreement as
amended hereby. 
  
 (c) Authority, Etc. The execution and
delivery by each of the Guarantors and the Borrower of this Amendment and the performance by each of the Guarantors and the Borrower of their respective agreements and obligations under the Credit Agreement as amended hereby are within the corporate
or partnership authority of each such Person and have been duly authorized by all necessary corporate or partnership action on the part of such Person. 
  
 (d) Enforceability of Obligations. This Amendment and the Credit Agreement as amended hereby constitute the legal, valid and binding obligations of
each of the Guarantors and the Borrower, enforceable against each such Person in accordance with their terms, except as enforceability is limited by bankruptcy, insolvency, reorganization, moratorium or other laws relating to, or affecting generally
the enforcement of, creditors’ rights and by equitable principles. 
  
 (e) No Default. No Default or Event of Default has occurred and is continuing (except as waived hereby), and no Default or Event of Default will exist after execution and delivery of, and after giving effect to, this Amendment.

  
 §7. Miscellaneous Provisions. (a)
Except as otherwise expressly provided by this Amendment, all of the terms, conditions and provisions of the Credit Agreement shall remain the same. It is declared and agreed by each of the parties hereto that the Credit Agreement, as amended or
waived hereby, shall continue in full force and effect, and that this Amendment and the Credit Agreement shall be read and construed as one instrument. 
  

 -5- 

 (b) THIS AMENDMENT IS INTENDED TO TAKE EFFECT AS AN AGREEMENT UNDER SEAL AND SHALL BE CONSTRUED ACCORDING
TO AND GOVERNED BY THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS (WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS). 
  
 (c) This Amendment may be executed in any number of counterparts, but all such counterparts shall together constitute but one instrument. In making proof
of this Amendment it shall not be necessary to produce or account for more than one counterpart signed by each party hereto by and against which enforcement hereof is sought. 
  
 (d) The Borrower hereby agrees to pay to the Administrative Agent, on demand by the Administrative Agent, all reasonable
legal fees and expenses incurred or sustained by the Administrative Agent in connection with the preparation of this Amendment. 
  
 [Remainder of page intentionally left blank] 
  

 -6- 

 IN WITNESS WHEREOF, each of the undersigned has caused this Amendment to be executed as of the date first
written above. 
  

	 BUCA, INC., as the Borrower
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	 Title: Executive Vice President and
           Chief Financial Officer

  

	 BUCA RESTAURANTS, INC., as a Guarantor
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

  

	 BUCA RESTAURANTS 2, INC., as a Guarantor
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

  

	 BUCA RESTAURANTS 3, INC., as a Guarantor
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

	 BUCA INVESTMENTS, INC., as a Guarantor
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

  

	 BUCA (KANSAS), INC., as a Guarantor
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

  

	 BUCA TEXAS RESTAURANTS, L.P., as a Guarantor
  

		
	By:	 	 BUCA Restaurants, Inc., its General Partner
  

		
	By:	 	/s/    Greg A. Gadel         
	 	

	 	 	Name: Greg A. Gadel
	 	 	Title: Chief Financial Officer

	 BUCA TEXAS BEVERAGE, INC., as a Guarantor
  

		
	By:	 	/s/    John James Morrison, Jr.         
	 	

	 	 	Name: John James Morrison, Jr.
	 	 	Title: President and Secretary

	 FLEET NATIONAL BANK, individually and as Administrative Agent
  

		
	By:	 	/s/    Heidi F. Tyng         
	 	

	 	 	Name: Heidi F. Tyng
	 	 	Title: Vice President

	 SUNTRUST BANK, individually and as Syndication Agent
  

		
	By:	 	/s/    Susan M. Hall         
	 	

	 	 	Name: Susan M. Hall
	 	 	Title: Managing Director

	 WELLS FARGO BANK, N.A.
  

		
	By:	 	/s/    Jeffrey H. Morsman         
	 	

	 	 	Name: Jeffrey H. Morsman
	 	 	Title: Assistant Vice President

	 U.S. BANK, NATIONAL ASSOCIATION
  

		
	By:	 	 
	 	

	 	 	Name:
	 	 	 Title:

 SCHEDULE 11.5.2 
  
 Stores 
  
 San Jose, California 
  
 Carlsbad, California 
  
 Thousand Oaks, California 
  
 Manchester, Connecticut

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}]]